JP2025508542A5 - - Google Patents
Info
- Publication number
- JP2025508542A5 JP2025508542A5 JP2024552725A JP2024552725A JP2025508542A5 JP 2025508542 A5 JP2025508542 A5 JP 2025508542A5 JP 2024552725 A JP2024552725 A JP 2024552725A JP 2024552725 A JP2024552725 A JP 2024552725A JP 2025508542 A5 JP2025508542 A5 JP 2025508542A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- pharmaceutically acceptable
- acceptable salt
- compound according
- halo
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263317740P | 2022-03-08 | 2022-03-08 | |
| US63/317,740 | 2022-03-08 | ||
| PCT/US2023/063643 WO2023172845A1 (en) | 2022-03-08 | 2023-03-03 | Pparg inverse agonists and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025508542A JP2025508542A (ja) | 2025-03-26 |
| JP2025508542A5 true JP2025508542A5 (enExample) | 2026-03-06 |
Family
ID=86006834
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024552725A Pending JP2025508542A (ja) | 2022-03-08 | 2023-03-03 | Ｐｐａｒｇインバースアゴニストおよびそれらの使用 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20250186425A1 (enExample) |
| EP (1) | EP4490147A1 (enExample) |
| JP (1) | JP2025508542A (enExample) |
| CN (1) | CN118984823A (enExample) |
| AU (1) | AU2023231613A1 (enExample) |
| CA (1) | CA3254011A1 (enExample) |
| WO (1) | WO2023172845A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3254026A1 (en) * | 2022-03-08 | 2023-09-14 | Flare Therapeutics Inc. | Inverse PPARG agonists and their uses |
| CN122122131A (zh) * | 2023-11-10 | 2026-05-29 | 北京丹擎医药科技有限公司 | 杂环衍生物及其组合物和应用 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL357678A1 (en) * | 2000-04-28 | 2004-07-26 | Sankyo Company, Limited | Ppargamma modulators |
| US20060217425A1 (en) * | 2005-03-14 | 2006-09-28 | Jack Burton | Methods of treating cancer using PPAR-gamma antagonists |
| CZ300589B6 (cs) * | 2006-09-04 | 2009-06-24 | Univerzita Palackého | Deriváty 2-fenyl-3-hydroxychinolin-4(1H)-onu a zpusob jejich prípravy a použití |
| CN105982884B (zh) * | 2015-02-25 | 2019-05-24 | 上海中医药大学 | 一种补骨脂二氢黄酮甲醚及其类似物的用途 |
| CN107661333B (zh) * | 2016-07-27 | 2020-12-29 | 清华大学 | 化合物在治疗肺癌中的应用 |
| CN107522657B (zh) * | 2017-09-28 | 2020-06-26 | 上海中医药大学 | 一种具有ppar多重激动活性的化合物及其制备方法和应用 |
| EP3498694A1 (en) * | 2017-12-12 | 2019-06-19 | Medibiofarma, S.L. | New benzamide derivatives as ppar-gamma modulators |
| JP7853310B2 (ja) * | 2021-03-02 | 2026-04-28 | フレア・セラピューティクス・インコーポレーテッド | Ｐｐａｒｇ逆アゴニストおよびその使用 |
| JP2024529534A (ja) * | 2021-08-05 | 2024-08-06 | フレア・セラビューティクス・インコーポレーテッド | Ｐｐａｒｇ逆アゴニストおよびその使用 |
-
2023
- 2023-03-03 AU AU2023231613A patent/AU2023231613A1/en active Pending
- 2023-03-03 CN CN202380033175.XA patent/CN118984823A/zh active Pending
- 2023-03-03 JP JP2024552725A patent/JP2025508542A/ja active Pending
- 2023-03-03 WO PCT/US2023/063643 patent/WO2023172845A1/en not_active Ceased
- 2023-03-03 CA CA3254011A patent/CA3254011A1/en active Pending
- 2023-03-03 EP EP23716983.4A patent/EP4490147A1/en active Pending
- 2023-03-03 US US18/844,419 patent/US20250186425A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024529534A5 (enExample) | ||
| JP2025508272A5 (enExample) | ||
| JP2021523221A5 (enExample) | ||
| CN115244058A (zh) | 嘧啶并二环类衍生物、其制备方法及其在医药上的应用 | |
| CN115605479A (zh) | 吡啶酮并嘧啶类衍生物、其制备方法及其在医药上的应用 | |
| JP2023518286A5 (enExample) | ||
| JP2021512059A5 (enExample) | ||
| JP2021512166A5 (enExample) | ||
| CN110573500A (zh) | N-(氮杂芳基)环内酰胺-1-甲酰胺衍生物及其制备方法和应用 | |
| HRP20250254T1 (hr) | Derivati 2‑aminopiridina ili 2‑aminopirimidina kao inhibitori kinaze ovisne o ciklinima | |
| JP2023527891A5 (enExample) | ||
| JP2016534134A5 (enExample) | ||
| JP2007511504A5 (enExample) | ||
| RU2018104092A (ru) | Бициклические лактамы и способы их применения | |
| JP2023528623A5 (enExample) | ||
| HRP20161478T1 (hr) | Inhibitori protein kinaze (varijante), njihova upotreba za liječenje neuroloških bolesti, kao i farmaceutski pripravak koji se na njima temelji | |
| JP2018533593A5 (enExample) | ||
| JP2021522166A5 (enExample) | ||
| JP2019518766A5 (enExample) | ||
| JP2021529814A5 (enExample) | ||
| RU2018138828A (ru) | Уменьшение массы опухоли путем введения ccr1 антагонистов в комбинации с pd-1 ингибиторами или pd-l1 ингибиторами | |
| JP2020504707A5 (enExample) | ||
| JP2023502458A5 (enExample) | ||
| JP2019529359A5 (enExample) | ||
| ES2908938T3 (es) | Nuevos derivados de benzamida como moduladores de PPAR-gamma |